King Kevin M 4
4 · iRhythm Technologies, Inc. · Filed Nov 16, 2020
Insider Transaction Report
Form 4
King Kevin M
DirectorPresident and CEO
Transactions
- Sale
Common Stock
2020-11-12$254.41/sh−5,438$1,383,478→ 264,326 total - Exercise/Conversion
Common Stock
2020-11-12$17.00/sh+17,918$304,606→ 260,019 total - Sale
Common Stock
2020-11-12$251.86/sh−2,210$556,619→ 271,560 total - Sale
Common Stock
2020-11-12$255.19/sh−9,724$2,481,502→ 254,602 total - Sale
Common Stock
2020-11-12$256.16/sh−9,659$2,474,277→ 244,943 total - Sale
Common Stock
2020-11-12$258.26/sh−2,152$555,776→ 242,101 total - Exercise/Conversion
Common Stock
2020-11-12$8.18/sh+1,959$16,025→ 261,978 total - Exercise/Conversion
Common Stock
2020-11-12$35.25/sh+11,792$415,668→ 273,770 total - Sale
Common Stock
2020-11-12$252.43/sh−1,796$453,362→ 269,764 total - Exercise/Conversion
Employee Stock Option (right to buy)
2020-11-12−17,918→ 0 totalExercise: $17.00From: 2017-09-21Exp: 2026-10-19→ Common Stock (17,918 underlying) - Exercise/Conversion
Employee Stock Option (right to buy)
2020-11-12−11,792→ 88,208 totalExercise: $35.25From: 2018-03-01Exp: 2027-02-16→ Common Stock (11,792 underlying) - Sale
Common Stock
2020-11-12$257.25/sh−690$177,504→ 244,253 total - Exercise/Conversion
Employee Stock Option (right to buy)
2020-11-12−1,959→ 0 totalExercise: $8.18From: 2019-12-15Exp: 2025-12-15→ Common Stock (1,959 underlying)
Footnotes (9)
- [F1]The option exercises and sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 10, 2020.
- [F2]This transaction was executed in multiple trades at prices ranging from $251.20 to $251.965 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F3]This transaction was executed in multiple trades at prices ranging from $252.221 to $253.60 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F4]This transaction was executed in multiple trades at prices ranging from $253.74 to $254.73 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F5]This transaction was executed in multiple trades at prices ranging from $254.75 to $255.745 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F6]This transaction was executed in multiple trades at prices ranging from $255.77 to $256.55 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F7]This transaction was executed in multiple trades at prices ranging from $257.22 to $257.285 per share. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.
- [F8]All of the shares subject to this option are fully vested and exercisable as of the date hereof.
- [F9]The option, originally granted for 100,000 shares, of which 11,792 shares have been exercised, vested as to 1/4 of the shares on March 1, 2018 and as to 1/36 of the remaining shares each month thereafter.